Modified nitrocefin-edta method to differentially quantify the induced l1 and l2 β-lactamases in stenotrophomonas maltophilia
Letters in Applied Microbiology ISSN 0266-8254
Modified nitrocefin-EDTA method to differentially quantifythe induced L1 and L2 b-lactamases in StenotrophomonasmaltophiliaR.-M. Hu1, K.-H. Chiang2, C.-W. Lin2 and T.-C. Yang2
1 Department of Biotechnology and Bioinformatics, Asia University, Taichung, Taiwan2 Department of Medical Laboratory Science and Biotechnology, China Medical University, Taichung, Taiwan
b-lactamase, ethylene diamine tetraaceticacid, L1, nitrocefin, Stenotrophomonas
Aim: To estimate the ethylene diamine tetraacetic acid (EDTA) concentration
at which the L1 enzyme activity in the cell extracts of Stenotrophomonas malto-philia can be mostly inhibited.
Methods and Results: The effective inhibition concentration of EDTA against
the L1 enzyme in the cell extracts was firstly evaluated by using the L2 isogenic
Laboratory Science and Biotechnology, China
mutant of S. maltophilia KJ, KJDL2, as the assayed strain. Approximately 92%
Medical University, Taichung 404, Taiwan. E-mail: tcyang@mail.cmu.edu.tw
L1 activity was inhibited by 10 mmol l)1 EDTA, which is 100-fold higher thanthat from previously reported protocols (0Æ1 mmol l)1). Three phylogenetic
2008 ⁄ 0724: received 28 April 2008, revised
clusters of L1 proteins were revealed from 11 clinical S. maltophilia isolates,
with a L1 protein divergence of 0–11%. The EDTA concentration required toinhibit the L1 enzymes of different phylogenetic clusters was estimated to be
10 mmol l)1. Conclusion: The previous nitrocefin-EDTA protocol for differentially quantify-ing the L1 and L2 activity in the cell extracts has been modified by raising theadded EDTA concentration to 10 mmol l)1. Significance and Impact of the Study: A rapid and accurate method for deter-mination of L1 and L2 activity will provide a convenient tool for enzyme char-acterization and induction mechanism study of S. maltophilia.
the enzyme activity (Saino et al. 1982). L2 is a serine
active-site b-lactamase, and its activity is inert to the inhi-
Stenotrophomonas maltophilia has gained increasing atten-
bition of EDTA (Saino et al. 1984). Based on the charac-
tion owing to its multiple antimicrobial resistances (Vart-
teristics of EDTA inhibition against L1, a strategy for the
ivarian et al. 1994; Alonso and Martinez 1997). Two
differential quantification of L1 and L2 in induced soni-
chromosomal-encoded b-lactamases, L1 and L2, have
cated extract preparations has been proposed (Gould
been reported as the candidates of b-lactam resistance. It
et al. 2004; Okazaki and Avison 2008). Briefly, the total
is well known that both b-lactamases are co-inducibly
induced b-lactamases activities, i.e. L1 and L2, are mea-
expressed, but the real induction mechanism has not yet
sured using nitrocefin as the substrate. Meanwhile, L2
been uncovered (Mett et al. 1988; Avison et al. 2002;
activity is determined with nitrocefin plus 0Æ1 mmol l)1
Okazaki and Avison 2008). Developing a convenient
EDTA. The difference between the two measurements is
method for differentially quantifying the induced L1 and
then used to represent the activity of the L1 enzyme. In
L2 of S. maltophilia is therefore a necessity for under-
our previous study, a constructed L2 mutant, KJDL2 (Hu
standing the expression of L1 and L2 b-lactamases. L1 is
et al. 2008), was used as the material for characterization
a Zn2+-dependent metalloenzyme, and 0Æ1 mmol l)1 eth-
ylene diamine tetraacetic acid (EDTA) can inhibit 93% of
0Æ1 mmol l)1 EDTA only partially inhibited b-lactamase
ª 2008 The AuthorsJournal compilation ª 2008 The Society for Applied Microbiology, Letters in Applied Microbiology 47 (2008) 457–461
Differential quantification of L1 and L2 b-lactamases
activity expressed by the induced KJDL2 (to be mentioned
focusing electrophoresis with in-gel nitrocefin staining to
later). This indicates that the aforementioned method
ensure that the sole active b-lactamase expressed in
may overestimate L2 activity, while the calculated L1
KHDL2 (and YWDL2) was the L1 enzyme.
activity is underestimated. As S. maltophilia is a species ofhigh genetic diversity, we further evaluated the inhibition
property of EDTA towards the L1 enzymes from differentisolates. Accordingly, a modified method for differentially
An overnight culture of each bacterium to be mated was
quantifying L1 and L2 b-lactamase activity in cell extracts
prepared using Luria-Bertani (LB) broth. The cultures of
donor strain and recipient strain were mixed in a 10 : 1ratio. Mixed cultures were spread on the nitrocellulosemembrane in the centre of a nutrient agar plate (no
antibiotics added) and then incubated overnight at 37°C. The recombinant strains were selected on LB agar
containing tetracycline (40 lg ml)1) and norfloxacin
Stenotrophomonas maltophilia KJ and its L1, L2 isogenic
mutants, KJDL1 and KJDL2, have been characterized inour previous study (Hu et al. 2008). Ten S. maltophilia
Preparation of sonicated b-lactamase extracts
isolates were isolated from clinical patients and confirmedby species-specific PCR (Whitby et al. 2000).
Sonicated extract preparations for the b-lactamase activityassay were done according to the procedure reported inour previous paper (Hu et al. 2008). In brief, an over-
Cloning and sequence analysis of L1 genes
night culture was inoculated into 20-ml fresh LB at a final
To amplify the L1 genes of the 10 isolates, a primer pair
turbidity of 0Æ15 OD450 and cultured at 37°C for 0Æ5 h.
L1–F2 (5¢-AAGGAGGCCCATGCTAGTTT-3¢) and L1–R2
Cefoxitin of 50 lg ml)1 was then added and incubated at
(5¢-TTCTGACCGGCACCCTTC-3¢) was designed (http://
37°C for 2 h. Bacterial cells were harvested, washed, and
www.sanger.ac.uk/Projects/Microbes/). The 50-ll PCR
resuspended in 2 ml of 50 mmol l)1 phosphate buffer
reaction mixture contained 10 ng genomic DNA, 50 pmol
(pH 7Æ0). The cell suspension was sonicated in an ultra-
forward and reverse primers, 2Æ5 mmol l)1 each of deoxy-
sonic disrupter (S-3000; Misonix, NY, USA) for 5 min in
nucleoside triphosphate, 1 · PCR buffer (Yeastern Bio-
an ice bath. The supernatant was used as a source for
tech Co., Taiwan) and 2Æ5 U of Taq DNA polymerase.
b-lactamase activity assay after centrifuging at 10 000 g
The PCR reaction consisted of one cycle of 10 min at
94°C, 30 cycles of 1 min at 94°C, 1 min at 52°C, and1 min at 72°C, followed by a final extension step at 72°C
for 10 min. The approximate 1-kb PCR product wasligated into T-vector (Yeastern Biotech Co., Taiwan) and
The b-lactamase activity of crude sonicated extracts was
measured by UV spectrophotometer as described previ-ously (Hu et al. 2008) with nitrocefin (Oxoid, UK)(100 lmol l–1) as the substrate. The wavelength and
absorption coefficient for nitrocefin were 486 nm and
Multiple sequence alignments were performed using the
20 500 mol)1 cm)1, respectively. One unit of b-lactamase
ClustalX program. Phlyogenetic trees were constructed
activity was defined as the amount of b-lactamase that
by a neighbor-joining method. The phylogenetic ‘cluster’
hydrolyzed 1 nmol of nitrocefin in 1 min at 30°C. Pro-
was defined as having a cutoff value of 96% identity.
tein concentration was determined using a Bio-Rad pro-tein assay reagent. The specific activity of the enzymewas defined in terms of units per mg protein in the cell
Construction of the L2 isogenic mutants of Stenotropho-
extracts. For the inhibition assay, various concentrations
of EDTA were preincubated with the assayed extracts for
The L2 genes of strains KH and YW were obtained by
10 min at 30°C prior to the b-lactamase activity
PCR strategy, and two recombinant plasmids for the con-
determination. The total reaction volume was 0Æ5 ml in
struction of the L2 isogenic mutants, pKHDL2 and
pYWDL2, were constructed as described previously (Hu
50 mmol l)1 phosphate buffer (pH 7Æ0). At least three
et al. 2008). Mutants KHDL2 and YWDL2 were obtained
independent experiments were conducted to determine
by conjugation and confirmed by PCR and isoelectric
Journal compilation ª 2008 The Society for Applied Microbiology, Letters in Applied Microbiology 47 (2008) 457–461
Differential quantification of L1 and L2 b-lactamases
mature L1 protein divergence among these 11 isolates
ranged from 0% to 11%, which is consistent with the
The sequences determined for the L1 genes of the 10 S.
previous findings (Hauben et al. 1999; Avison et al.
maltophilia isolates and for the L2 genes of strains KH
2001). Figure 1 shows a phylogenetic tree for mature L1
and YW have been deposited in GenBank under accession
proteins, which can be divided into three distinct phylo-
numbers EF126061 (KJa, L1), EF126053 (KJb, L1),
genetic clusters (L1-1 to L1-3). The inter-cluster L1
EF126054 (KJc, L1), EU441218 (KH, L1), EF126056 (YW,
enzymes displayed a protein identity ranging from 89%
to 92%. The members with an 873-nt L1 gene, including
EF126058 (YWc, L1), EF126063 (YWd, L1), EF126065
our previous isolate KJ, belonged to cluster L1-1, whereas
(YWe, L1), EU032534 (KH, L2), and EF126080 (YW, L2),
the members of L1-2 and L1-3 all contained 870 nt. Iso-
lates KJ, KH and YW were selected as the representativesfor clusters L1-1, L1-2 and L1-3, respectively, for furtherstudy.
EDTA-inhibition property of Stenotrophomonas
EDTA-inhibition property on the b-lactamase activity of
different Stenotrophomonas maltophilia isolates andmutants
The sole active b-lactamases inducibly expressed in KJDL1and KJDL2 are L2 and L1 enzymes, respectively (Hu et al.
Table 1 shows the cell-extract b-lactamase activity of
2008). Table 1 shows the inhibitory effect of EDTA on
S. maltophilia KHDL2 and YWDL2, both with and with-
the b-lactamase activity expressed in the cell extracts of
out EDTA as an inhibitor. The percentages of b-lactamase
KJDL1 and KJDL2. Apparently, EDTA effectively inhibited
activity inhibited by 0Æ1 mmol l)1 and 10 mmol l)1 EDTA
L1 activity, but hardly affected L2 activity. An EDTA con-
were 51% and 98% for mutant KHDL2, and 87% and
centration to inhibit the most L1 b-lactamase activity
93% for mutant YWDL2. To gain a better understanding
(>90%) was as high as 10 mmol l)1.
of the inhibition effect of 0Æ1 mmol l)1 and 10 mmol l)1EDTA on the cell-extract b-lactamase activity of theS. maltophilia isolates; the b-lactamase activity of the 11
isolates were determined in the presence of 0, 0Æ1 and
Sequencing of these 10 PCR amplicons revealed that the
10 mmol l)1 EDTA, respectively (Table 2). For each
L1 genes were of two different lengths, 870 and 873 bp,
isolate, EDTA displayed a significant inhibition of b-lac-
encoding a preprotein of 289 and 290 amino acid resi-
tamase activity. Activity in the presence of 10 mmol l)1
dues. After the predicted signal peptide of 20 or 21 amino
EDTA was notably lower than that of 0Æ1 mmol l)1.
acids had been deducted, all the tested isolates had amature 269-amino acid L1 protein. As the reported L1
sequence of isolate KJ (Hu et al. 2008) was included, the
The active b-lactamase solely presented in mutantsKJDL2, KHDL2 and YWDL2 is the L1 enzyme, as con-
Table 1 The inhibitory effect of ethylene diamine tetraacetic acid
firmed by isoelectric focusing electrophoresis with in-gel
(EDTA) on the b-lactamase activity expressed in the cell extracts of
nitrocefin staining (data not shown). Furthermore, the L1
enzymes of different phylogenetic clusters show different
susceptibility towards the action of EDTA (Table 1). The
L1 enzyme of strain YW is the one most susceptible to
EDTA; 0Æ1 mmol l)1 EDTA is enough to inhibit most L1activity (87%). Conversely, L1 enzymes of strains KJ and
KH display less susceptibility to EDTA; therefore, a higher
EDTA concentration, i.e. 10 mmol l)1, is essential to
impose significant inhibition. Saino et al. (1982) purified
L1 enzyme from S. maltophilia GN12873 and demon-
strated that 0Æ1 mmol l)1 EDTA is enough to inhibit thepurified L1 enzyme. However, only 36–87% of L1 enzyme
*One unit of b-lactamase is defined as 1 nm of nitrocefin hydrolysed
activity in sonicated extracts in the present study is inhib-
per minute per mg protein. Results are geometric means of threeindependent determinations. Standard deviations were within 10% of
ited by 0Æ1 mmol l)1 EDTA. The EDTA inhibition effect
on L1 enzyme in the sonicated extract preparations is
ª 2008 The AuthorsJournal compilation ª 2008 The Society for Applied Microbiology, Letters in Applied Microbiology 47 (2008) 457–461
Differential quantification of L1 and L2 b-lactamases
protein sequences of Stenotrophomonasmaltophilia isolates. L1 genes from the 11
clinical strains of S. maltophilia isolated in
Phylogenetic distances were determined byneighbor-joining analysis. Numbers near a
node represent the percentage of bootstrap
apparently less significant than that on the purified L1
different strains. As can be seen in Table 2, the EDTA
enzyme, implying that there are factors within the extracts
susceptibility for L1 enzymes of the three phylogenetic
that counteract the inhibition effect of EDTA.
clusters is generally, in order, L1-3, L1-2 and L1-1. Gould
Because S. maltophilia is a genus of high genetic diver-
et al. proposed a strategy for differential quantification of
sity, as reported in the L1 allele with a diversity of 20%
L1 and L2 in an induced sonicated extracts preparation
(Hauben et al. 1999; Avison et al. 2001), it is likely that
based on the characteristics of EDTA inhibition against
the EDTA-inhibited level of the L1 enzymes differs in the
L1 (Gould et al. 2004). In Gould’s study, 0Æ1 mmol l)1EDTA was employed, which apparently overestimated theL2 activity, while underestimating the L1 activity. This is
Table 2 The inhibitory effect of ethylene diamine tetraacetic acid
because 0Æ1 mmol l)1 EDTA is insufficient for inhibiting
(EDTA) on the b-lactamase activity expressed in the cell extracts ofStenotrophomonas maltophilia strains
the activity of L1 enzyme. Instead, 10 mmol l)1 EDTA isthe optimal concentration for the inhibition of L1
10 mmol l)1 EDTA can inhibit 92–98% L1 activities of
different S. maltophilia L2 isogenic mutants. The inhibi-tion of L1 activity is enhanced insignificantly even though
the EDTA concentration is as high as 50 mmol l)1.
Table 2 also shows that the L1 b-lactamase activity of
strain KJ can be obtained in two different ways: one by
the mutant KJDL2 in the assayed condition of 0 mmol l)1
EDTA (432 U mg)1) and the other by subtracting the
b-lactamase activity of strain KJ in 0 mmol l)1 EDTA
from that in 10 mmol l)1 EDTA (402 U mg). Both show
good consistency, indicating that 10 mmol l)1 EDTA
indeed effectively inhibited L1 activity. Pair-wise compari-
sons among strains KH ⁄ KHDL2 and YW ⁄ YWDL2 also
gave similar results. Therefore, we propose a modified
nitrocefin–EDTA method to differentially quantify theinduced L1 and L2 b-lactamases in the cell extracts of S.
*One unit of b-lactamase is defined as 1 nm of nitrocefin hydrolysed
maltophilia. The b-lactamase activities of the assayed
per minute per mg protein. Results are geometric means of threeindependent determinations. Standard deviations were within 10% of
extracts were determined with and without 10 mmol l)1
EDTA. In the absence of EDTA, the detected b-lactamase
Journal compilation ª 2008 The Society for Applied Microbiology, Letters in Applied Microbiology 47 (2008) 457–461
Differential quantification of L1 and L2 b-lactamases
activity (Unitrocefin) represents the sum of L1 and L2 activ-
Hauben, L., Vauterin, L., Moore, E.R.B., Hoste, B. and Swings,
ity. Because most L1 activity is inhibited by 10 mmol l)1
J. (1999) Genomic diversity of the genus Stenotrophomon-
as. Int J Syst Bacteriol 49, 1749–1760.
Hu, R.-M., Huang, K.-J., Wu, L.-T., Hsiao, Y.-J. and Yang, T.-C.
from the L2 enzyme. Accordingly, the L1 enzyme can be
(2008) Induction of L1 and L2 b-lactamases of Stenotroph-
calculated by subtracting the activity of U
omonas maltophilia. Antimicrob Agents Chemother 52,
Mett, H., Rosta, S., Schacher, B. and Frei, R. (1988) Outer
membrane permeability and b-lactamase content in Pseu-
domonas maltophilia clinical isolates and laboratorymutants. Rev Infect Dis 10, 765–769.
This research was supported by grant nos. CMC93-MT-
Okazaki, A. and Avison, M.B. (2008) Induction of L1 and L2
03 and CMU95-102 to T.-C. Yang from the China Medi-
b-lactamase production in Stenotrophomonas maltophilia is
dependent on an AmpR-type regulator. Antimicrob AgentsChemother 38, 2143–2149.
Saino, Y., Kobayashi, F., Inoue, M. and Mitsuhashi, S. (1982)
Purification and properties of inducible penicillin b-lac-
Alonso, A. and Martinez, J.I. (1997) Multiple antimicrobial
tamase isolated from Pseudomonas maltophilia. Antimicrob
resistance in Stenotrophomonas maltophilia. Antimicrob
Saino, Y., Inoue, M. and Mitsuhashi, S. (1984) Purification
Avison, M.B., Higgins, C.S., von Heldreich, C.J., Bennett, P.M.
and properties of an inducible cephalosporinase from
and Walsh, T.R. (2001) Plasmid location and molecular
Pseudomonas maltophilia GN12873. Antimicrob Agents
heterogeneity of the L1 and L2 b-lactamase genes of Steno-
trophomonas maltophilia. Antimicrob Agents Chemother 45,
Vartivarian, S., Anaissie, E., Bodey, G., Sprigg, H. and Rol-
ston, K. (1994) A changing pattern of susceptibility of
Avison, M.B., Higgins, C.S., Ford, P.J., von Heldreich, C.J.,
Xanthomonas maltophilia to antimicrobial agents: impli-
Walsh, T.R. and Bennett, P.M. (2002) Differential regula-
cations for therapy. Antimicrob Agents Chemother 38,
tion of L1 and L2 b-lactamase expression in Stenotropho-
monas maltophilia. J Antimicrob Chemother 49, 387–389.
Whitby, P.W., Carter, K.B., Burns, J.L., Royall, J.A., Lipuma,
Gould, V.C., Okazaki, A., Howe, R.A. and Avison, M.B. (2004)
J.J. and Stull, T.L. (2000) Identification and detection of
Analysis of sequence variation among smeDEF multi drug
Stenotrophomonas maltophilis by rRNA-directed PCR.
efflux pump genes and flanking DNA from defined 16S
rRNA subgroups of clinical Stenotrophomonas maltophiliaisolates. J Antimicrob Chemother 54, 348–353.
ª 2008 The AuthorsJournal compilation ª 2008 The Society for Applied Microbiology, Letters in Applied Microbiology 47 (2008) 457–461
ANN C. THOMAS 9 Caldwell Drive • Philadelphia, PA 19106 • (215) 646-8741 • ann.thomas@glaxo.com SUMMARY OF QUALIFICATIONS Sales and marketing oriented Pharmaceutical Industry professional providing focused education and practical experience in building a strong foundation towards a career in Pharmaceutical sales. Demonstrate broad-based strengths in: Sales & Marke
September MIMS Monthly Medicine Update NEW PRODUCTS Priligy (dapoxetine hydrochloride) Zaltrap (aflibercept (rch)) is a Erivedge (vismodegib) is a low severe chronic neutropenia (SCN); and in endothelial growth factor (VEGF) receptor (1 and 2) extracellular domains fused to HIV therapy. Zarzio is contraindicated in ejaculatory latency time (IELT) of less than patients with kn